Answers are grounded in this paper and cite their sources.
Objective To evaluate the effects of a combined perioperative microbiota-targeted intervention on short-term clinical outcomes, perioperative immune indices, and gut microbiota changes after definitive surgery in children with Hirschsprung disease (HD). Methods Sixty children with HD who underwent Soave pull-through surgery at Shanghai Children's Medical Center Guizhou Hospital between December 2025 and June 2026 were randomly assigned to an intervention group or a control group (30 children per group). All participants had short-segment HD. The control group received routine perioperative treatment. In addition to routine care, the intervention group received oral Bifidobacterium-Lactobacillus triple viable tablets, Clostridium butyricum viable powder, and glutamine during the perioperative period, together with total enteral nutritional support individualized to nutritional status. Clinical recovery and perioperative complications were compared, with structured telephone follow-up at 3 months after surgery. IL-6, TNF-alpha, CRP, IgA, IgG, C3, and C4 were measured 1 day before surgery and on postoperative days 3 and 7. Fecal samples were collected 3 days before surgery and 2 weeks after surgery for analysis of Shannon, Simpson, and Chao1 indices, major genera, principal coordinates analysis (PCoA), and differential genera. Results The intervention group had a shorter hospital stay than the control group [15.0 (13.0, 17.8) vs. 18.0 (15.3, 20.8) days; P = 0.005] and earlier first postoperative flatus (47.4 +/- 12.6 vs. 75.4 +/- 14.1 h; P < 0.001). HAEC was numerically lower in the intervention group than in the control group (6.7% vs. 20.0%; RR = 0.33, 95% CI 0.07 to 1.52; absolute risk difference = -13.3 percentage points, 95% CI -31.3 to 4.7; Fisher's exact P = 0.254). Overall perioperative complications were also numerically lower (23.3% vs. 40.0%; RR = 0.58, 95% CI 0.27 to 1.28; absolute risk difference = -16.7 percentage points, 95% CI -37.8 to 6.7; Fisher's exact P = 0.267). Event numbers were small. Postoperative TNF-alpha levels were lower in the intervention group (P < 0.01), and CRP on postoperative day 3 was lower (P = 0.045). Postoperative IgA and C4, C3 on day 3, and IgG on day 7 were higher in the intervention group (P < 0.05). Postoperative Shannon, Simpson, and Chao1 indices were higher in the intervention group (all P < 0.01). The postoperative relative abundances of Bifidobacterium and Lactobacillus increased in the intervention group, and PCoA indicated differences in overall postoperative community structure between groups (P < 0.01). Correlation analyses suggested exploratory trends between selected genera and inflammatory or immune indices. Conclusion A combined perioperative microbiota-targeted intervention may promote postoperative gut microbiota recovery, attenuate inflammation, improve selected immune indices, accelerate bowel function recovery, and shorten hospitalization in children with HD. HAEC and overall perioperative complications were numerically lower in the intervention group, although these findings remain inconclusive because events were few. Larger studies with longer follow-up are needed.
No takes yet. Share an insight, caveat, or question.
庄依泽 et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: